Jubilant is the fourth company to launch its licensed generic brand of remdesivir after Hetero Drugs, Cipla and Mylan.Gilead has given the firms the license on a royalty-free basis till an alternative drug is discovered
from Livemint - Companies https://ift.tt/30nmIZs
https://ift.tt/eA8V8J
Monday, August 3, 2020
Jubilant Life arm launches covid drug remdesivir as JUBI-R at ₹4,700/vial
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment